Advanced Proteome Therapeutics APTCF Stock
0.0002 USD
{{ price }}
-99.455040%
{{change_pct}}%
COUNTRY
United States
Exchange
Other OTC
Market Cap
149.63K USD
LOW - HIGH [24H]
0.0002
-
0.0002 USD
VOLUME [24H]
14.49K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.06 USD
Advanced Proteome Therapeutics Price Chart
Advanced Proteome Therapeutics APTCF Financial and Trading Overview
Advanced Proteome Therapeutics stock price | 0.0002 USD |
Previous Close | 0.0002 USD |
Open | 0.0002 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 0.0002 - 0.0002 USD |
52 Week Range | 0.0002 - 0.09 USD |
Volume | 14.31K USD |
Avg. Volume | 230 USD |
Market Cap | 8.23K USD |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.06 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
APTCF Valuation Measures
Enterprise Value | N/A |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
Advanced Proteome Therapeutics Stock Price History
Beta (5Y Monthly) | N/A |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 0.09 USD |
52 Week Low | 0.0002 USD |
50-Day Moving Average | 0.02 USD |
200-Day Moving Average | 0.05 USD |
APTCF Share Statistics
Avg. Volume (3 month) | 230 USD |
Avg. Daily Volume (10-Days) | 0 USD |
Shares Outstanding | N/A |
Float | N/A |
Short Ratio | N/A |
% Held by Insiders | N/A |
% Held by Institutions | N/A |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor | N/A |
Financial Highlights
Fiscal Year
Fiscal Year Ends | N/A |
Most Recent Quarter (mrq) | N/A |
Next Fiscal Year End | N/A |
Profitability
Profit Margin | N/A |
Operating Margin (ttm) | N/A |
Gross Margin | N/A |
EBITDA Margin | N/A |
Management Effectiveness
Return on Assets (ttm) | N/A |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | N/A |
Net Income Avi to Common (ttm) | N/A |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | N/A |
Total Cash Per Share (mrq) | N/A |
Total Debt (mrq) | N/A |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | N/A |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Q&A For Advanced Proteome Therapeutics Stock
What is a current APTCF stock price?
Advanced Proteome Therapeutics APTCF stock price today per share is 0.0002 USD.
How to purchase Advanced Proteome Therapeutics stock?
You can buy APTCF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Advanced Proteome Therapeutics?
The stock symbol or ticker of Advanced Proteome Therapeutics is APTCF.
How many shares does Advanced Proteome Therapeutics have in circulation?
The max supply of Advanced Proteome Therapeutics shares is 748.15M.
What is Advanced Proteome Therapeutics Price to Earnings Ratio (PE Ratio)?
Advanced Proteome Therapeutics PE Ratio is now.
What was Advanced Proteome Therapeutics earnings per share over the trailing 12 months (TTM)?
Advanced Proteome Therapeutics EPS is -0.06 USD over the trailing 12 months.